Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir
Clinical trial NCT03095638 · COMPLETED
Trial details
- NCT number
- NCT03095638
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-03
- Primary completion
- 2017-06-23
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.